Polymorphisms of tumor-necrosis factor-α−308 and lymphotoxin-α + 250: Possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells

References

• Salles G, Bienvenu J, Bastion Y, Barbier Y, Doche C, Warzocha K, et al. Elevated circulating levels of TNFα and its p55soluble receptor are associated with an adverse prognosis inlymphoma patients. Br J Haematol 1996; 93: 352–359
   PubMed Web of Science ®Google Scholar
• Waage A, Liabakk N, Lien E, Lamvik J, Espevik T. p55 and p75 Tumor necrosis factor receptors in patients with chronic lymphocytic leukemia. Blood 1992; 80: 2577–2583
   PubMed Web of Science ®Google Scholar
• Warzocha K, Salles G, Bienvenu J, Bastion Y, Dumontet C, Renard N, et al. Tumour necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol 1997; 15: 499–508
   PubMed Web of Science ®Google Scholar
• Kung A L, Zetterberg A, Sherwood S W, Schimke R T. Cytotoxic effects of cell cycle phase specific agents: result of cell cycle perturbation. Cancer Res 1990; 50: 7307–7317
   PubMed Web of Science ®Google Scholar
• Arends M J, Morris R G, Wyllie A H. Apoptosis: the role of the endonuclease. Am J Pathol 1990; 136: 593–608
   PubMed Web of Science ®Google Scholar
• Browning J L, Ngam-ek A, Lawton P, DeMarinis J, Tizard R, Chow E P, et al. Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993; 72: 847–856
   PubMed Web of Science ®Google Scholar
• Hajeer A H, Hutchinson I V. TNF-α gene polymorphism: clinical and biological implications. Microsc Res Techn 2000; 50: 216–228
   PubMed Web of Science ®Google Scholar
• Messer G, Spengler U, Jung M C, Honold G, Blomer K, Pape G R, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173: 209
   PubMed Web of Science ®Google Scholar
• Pociot F, Briant L, Jongeneel C V, Mölvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224–231
   PubMed Web of Science ®Google Scholar
• Bouma G, Crusius J B, Oudkerk Pool M, Kolkman J J, von Blomberg B M, et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphism in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996; 43: 456–463
   Google Scholar
• Fisher D E. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539
   PubMed Web of Science ®Google Scholar
• Waterer G W, Quasney M W, Cantor R M, Wunderink R G. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001; 163: 1599–1604
   PubMed Web of Science ®Google Scholar
• Bøyum A. Isolation of human blood monocytes with nycodenz – a new non-ionic iodinated gradient medium. J Immunol 1983; 17: 429–436
   Web of Science ®Google Scholar
• Bartholeyns J, Peeters-Joris C, Reychler H, Baudhun P. Hepatic nucleases 1. Method for the specific determination and characterization in rat liver. Eur J Biochem 1975; 57: 205–211
   Google Scholar
• van Kooten C, Rensink I, Aarden L, van Oers R. Cytokines and intracellular signals involved in the regulation of B-CLL proliferation. Leuk Lymphoma 1993; 12: 27–33
   PubMed Web of Science ®Google Scholar
• Boussiotis V A, Nadler L M, Strominger J L, Goldfeld A E. Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc Natl Acad Sci USA 1994; 91: 7007–7011
   PubMed Web of Science ®Google Scholar
• Hoffbrand A V, Panayiotidis P, Reittie J, Ganeshaguru K. Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin Hematol 1993; 30: 306–317
   PubMed Web of Science ®Google Scholar
• Foa R, Massaia M, Cardona S, Tos A G, Bianchi A, Attisano C, et al. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. Blood 1990; 76: 393–400
   PubMed Web of Science ®Google Scholar
• Gibbons P L, Rowe M, Cope A P, Feldmann M, Brennan F M. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differential Burkitt lymphoma cell lines. Eur J Immunol 1994; 24: 1879–1893
   PubMed Web of Science ®Google Scholar
• Gruss H J, Dower S K. TNF Ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995; 85: 3378–3404
   PubMed Web of Science ®Google Scholar
• Wihlborg C, Sjoberg J, Intaglietta M, Axdorph U, Pisa E J, Pisa P. Tumour necrosis factor-α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukemia. Br J Haematol 1999; 104: 346–349
   PubMed Web of Science ®Google Scholar
• Mainou-Fowler T, Dickinson A M, Taylor P RA, Mounter P, Jack F, Proctor S J, et al. Tumor necrosis factor gene polymorphisms in lymphoproliferative disease. Leuk Lymphoma 2000; 38: 547–552
   PubMed Web of Science ®Google Scholar
• Demeter J, Porzsolt F, Ramisch S, Schmidt D, Schmidt M, Messer G. Polymorphism of the tumor necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukemia. Br J Haematol 1997; 97: 107–112
   PubMed Web of Science ®Google Scholar
• Seidemann K, Zimmermann M, Book M, Meyer U, Burkhardt B, Welte K, et al. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: resultsfrom Berlin-Frankfurt-Munster trial NHL-BFM 95. J Clin Oncol 2005; 23: 8414–8421
   PubMed Web of Science ®Google Scholar
• Sullivan K E, Wooten C, Schmeckpeper D, Goldman D, Petri M. A promoter polymorphism of tumor necrosis alpha is associated with systemic lupus erythematosus in African Americans. Arthritis Rheum 1997; 40: 2207–2211
   PubMed Web of Science ®Google Scholar
• Cebrera M, Shaw M A, Sharples C, Williams H, Castes M, Convit J, Blackwell J M. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259–1264
   PubMed Web of Science ®Google Scholar
• McGuire W, Hill A V, Allsoo C E, Greenwood B M, Kwiatkowski D. Variation in the TNF-alpha promoter region asociated with susceptibility to cerebral malaria. Nature 1994; 371: 508–510
   PubMed Web of Science ®Google Scholar
• Mira J P, Cariou A, Grall F, Delclaux C, Losser M R, Heshmati F, et al. Association of TNF2 – a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multycenter study. JAMA 1999; 282: 561–568
   PubMed Web of Science ®Google Scholar
• Kazzi S N, Jacques S M, Qureshi F, Quasney M W, Kim U O, Buhimschi I A. Tumor necrosis factor-alpha allele lymphotoxin-alpha + 250 is associated with the presence and severity of placental inflammation among preterm births. Pediatr Res 2004; 56: 94–98
   PubMed Web of Science ®Google Scholar
• Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91: 3574–3581
   PubMed Web of Science ®Google Scholar
• Messmer B T, Messmer D, Allen S L, Kolitz J E, Kudalkar P, Cesar D, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005; 115: 755–764
   PubMed Web of Science ®Google Scholar
• Fahey J L, Bogs D R. Serum protein changes in malignant disease I. The acute leukemias. Blood 1960; 16: 1479
   Google Scholar
• Gavasto F, Marinc C, Pileri A. Proliferative capacity of acute leukemia cells. Nature 1960; 187: 611
   PubMed Web of Science ®Google Scholar